Nanomedicine is the application of nanotechnology to achieve innovation in healthcare. It uses the properties developed by a material at its nanometric scale 10-9 m which often differ in terms of physics, chemistry or biology from the same material at a bigger scale.

Moreover, the nanometric size is also the scale of many biological mechanisms in the human body allowing nanoparticles and nanomaterials to potentially cross natural barriers to access new sites of delivery and to interact with DNA or small proteins at different levels, in blood or within organs, tissues or cells.

Key reasons to become a member:

Meet new partners and end-users
Share your success stories
Benefit from unique advantages
Shape the future of Nanomedicine in europe
Promote and educate

Know more

ETPN strategic inputs

As a major pan-European industry-oriented initiative, the ETPN aims at strengthening Europe’s capabilities and competitiveness in the area of nanomedicine innovation. Since 2005 the ETPN published a number of strategic documents outlining the needs and roadmaps for nanomedicine research in Europe.

We have contributed to set up numerous European funded projects providing a first impression of the conditions for a suitable social and economic environment and the structural requirements for an efficient translation of R&D results into innovative nanomedicine.

Know more

ETPN support to innovation

Complementary to its strategic inputs as an ETP to shape and support public funding on the most promising areas of Nanomedicine, the ETPN has designed in 2014 unique technical infrastructures regrouped in a central instrument: the Nanomedicine Translation HUB.

These free of charge services support and accelerate the development of the best Nanomedicine projects from innovative design to clinical development.

Know more

Are you on the Nanomedicine map?

The NanoMed Map provides thorough insights into the nanomedicine community by showing all the actors of the ecosystem in Europe and beyond. It was initiated by NanoMed 2020, CSA project under FP7_Health.

See the map



Latest news

ETPN Stepping into a Strategic Role in ERA4Health – A New Era for Nanomedicine & Healthtech in Europe

Jul 6, 2023

Dear ETPN members, dear colleagues from the European Nanomedicine community, we are delighted to share that the ETPN has been invited to join the ERA4Health's Strategic Advisory Board. This engagement paves the way for new significant advancements and funding for...

Participate in the ASTM Interlaboratory Studies on Liposomal Lipid Quantitation (summer 2023)

May 24, 2023

The European Technology Platform on Nanomedicine (ETPN) invites its members to partake in a scientific initiative by the FDA/ASTM International Committee E56 on Nanotechnology. The committee is conducting Interlaboratory Studies to assess the precision and bias of liposomal lipid quantitation methods. This initiative offers participating labs the chance to contribute to nanomedicine’s evolution, particularly in relation to standardization and metrological needs. The ETPN also highlights the upcoming launch of the MetrINo project, an innovative European endeavor set to contribute significantly to the Nanomed Europe 2023 conference and the broader nanomedicine landscape.